Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
JOHNSON & JOHNSON | 05-10-2024 | 03-31-2024 | 22 | 4,413,028,814 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
Kenvue Inc. | COM | 1 | $3,912,792,143 | 182,329,550 | 0.09 | 182,329,550 | +Inf | 03-31-2024 | |
Fusion Pharmaceuticals Inc. | COM | 2 | $78,255,401 | 3,670,516 | 0.00 | 0.01 | 0 | 0.00 | 03-31-2024 |
CVRx, Inc. | COM | 3 | $74,723,460 | 4,103,430 | 0.00 | 0.02 | 607,855 | 17.39 | 03-31-2024 |
Protagonist Therapeutics Inc. | COM | 4 | $70,854,864 | 2,449,183 | 0.00 | 0.02 | 0 | 0.00 | 03-31-2024 |